Please ensure Javascript is enabled for purposes of website accessibility

Why Investors Should Expect More Mergers Throughout 2015

By Dan Caplinger - Mar 30, 2015 at 11:11AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cash is burning a hole in many companies' pockets.

Healthcare M&A is picking up. Image:, Flickr.

The stock market roared ahead to strong gains Monday morning, as investors found multiple causes for optimism. Signs of recovery in the global economy helped create a positive tone before the market opened, and the Dow Jones Industrials (^DJI -0.11%) was up more than 250 points as of 11:20 a.m. EDT. Among the Dow's movers, UnitedHealth Group (UNH 1.22%) drew the lion's share of attention as the company made a big strategic purchase. As 2015 continues, we are likely to see more merger and acquisition activity of the same sort.

M&A on the rise
UnitedHealth is buying pharmacy benefits manager Catamaran (CTRX.DL) for $12.8 billion, or $61.50 per share. Predictably, Catamaran soared on the news, with shares climbing almost 25% to $60. Yet investors were also pleased with UnitedHealth's decision, sending the company's stock up between 2% and 3%.

Source: Catamaran.

For UnitedHealth, the deal reflects the changing landscape in the way U.S. consumers get healthcare. Drugstore chains CVS Health (CVS 1.88%) and Rite Aid (RAD 1.65%) have both incorporated pharmacy benefit management companies into their corporate structure, gaining broader negotiating power in dealing with pharmaceutical companies. By buying Catamaran, UnitedHealth will unite the third and fourth largest PBMs in the U.S. market, with its OptumRx unit already having substantial influence in the industry. Looking forward, UnitedHealth should gain more bargaining power not only with drugmakers but also with the pharmacies it works with.

Investors are starting to see a greater amount of M&A activity in general. Elsewhere in healthcare, pharmaceutical and biotechnology companies continue to consolidate as more mature companies seek out growth prospects from younger, more speculative peers that have promising compounds or treatments that could drive future sales.

Several other industries also show significant promise in powering M&A deals. The struggling energy industry has a number of companies that will fight to get enough cash flow as revenue plunges due to falling oil and natural gas prices that will challenge future plans for capital expenditures to build up long-term production. Temporary cash shortages will give larger companies with more financial latitude a huge amount of leverage to negotiate attractive deals to acquire or create partnerships with their smaller peers, potentially opening up huge new long-term opportunities once energy prices recover.

The one potential obstacle to rising M&A activity is the interest rate environment. Financing is cheap at the moment, but many anticipate rising rates in the near future, and that could start to put the brakes on companies obtaining the necessary funding for some mergers and acquisitions. Yet for the many companies that have spent billions of dollars on dividends and stock buybacks, simply diverting some of that capital back toward acquisitions in order would keep the M&A growth trend moving forward.

Investors always like to see M&A activity as it tends to send individual stocks higher. When you add up all the activity in the market, though, M&A has the capacity to send the Dow further upward in 2015.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool recommends Catamaran, CVS Health, and UnitedHealth Group. The Motley Fool owns shares of Catamaran. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
$32,795.91 (-0.11%) $-36.63
UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
$543.14 (1.22%) $6.54
CVS Health Corporation Stock Quote
CVS Health Corporation
$103.92 (1.88%) $1.92
Rite Aid Corporation Stock Quote
Rite Aid Corporation
$9.24 (1.65%) $0.15
Catamaran Corporation Stock Quote
Catamaran Corporation

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.